000 | 01450 a2200433 4500 | ||
---|---|---|---|
005 | 20250512110020.0 | ||
264 | 0 | _c19750503 | |
008 | 197505s 0 0 eng d | ||
022 | _a0069-0120 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGeran, R I | |
245 | 0 | 0 |
_aA mouse ependymoblastoma as an experimental model for screening potential antineoplastic drugs. _h[electronic resource] |
260 |
_bCancer chemotherapy reports. Part 2 _cDec 1974 |
||
300 |
_a53-87 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAlkylating Agents _xtherapeutic use |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
650 | 0 | 4 |
_aBrain Neoplasms _xdrug therapy |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aDrug Evaluation, Preclinical |
650 | 0 | 4 |
_aEpendymoma _xdrug therapy |
650 | 0 | 4 |
_aFolic Acid _xtherapeutic use |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 |
_aNeoplasms, Experimental _xdrug therapy |
650 | 0 | 4 |
_aNitrogen Mustard Compounds _xtherapeutic use |
650 | 0 | 4 |
_aNitrosourea Compounds _xtherapeutic use |
650 | 0 | 4 |
_aPurines _xtherapeutic use |
650 | 0 | 4 |
_aSteroids _xtherapeutic use |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aCongleton, G F | |
700 | 1 | _aDudeck, L E | |
700 | 1 | _aAbbott, B J | |
700 | 1 | _aGargus, J L | |
773 | 0 |
_tCancer chemotherapy reports. Part 2 _gvol. 4 _gno. 4 _gp. 53-87 |
|
999 |
_c4452487 _d4452487 |